All members
of the Board of Directors serve in their personal capacity and
do not represent the views of their organization during Board
activities.
All members of the Board of Directors annually
disclose any conflicts of interest concerning business
relationships with the Society.
No member of the 2009-2010 Board of Directors has disclosed any conflict of interest.
2009-2010 ISPOR Board of Directors
President (2009-2010)
Michael Barry MD, PhD, FRCPI
Clinical Director
National Centre for Pharmacoeconomics
St. James's Hospital
& Senior Lecturer in Clinical Pharmacology
Trinity College Dublin
Dublin, Ireland
Email: mbarry@STJAMES.IE
Chris L. Pashos PhD
Vice President
HERQuLES: Health Economic Research and Quality of Life Evaluation Services
Abt Bio-Pharma Solutions, Inc.
Lexington, MA, USA
Email: chris.pashos@abtbiopharma.com
Director (2009-2011)
Ansgar Hebborn PhD
Head - Global Payer & HTA Program Policy
F. Hoffmann-La Roche AG
Global Health Economics & Pricing (GHEP)
Basel, Switzerland
Email: ansgar.hebborn@roche.com
Shanlian Hu MD, MSc
Director and Professor
Training Center for Health Management
School of Public Health, Fudan University
Shanghai, P.R. China
Email: hushanlian@hotmail.com
Director (2008-2011)
Paul Kind
Professor
Centre for Health Economics
Alcuin College, University of York
York, United Kingdom
Email: pk1@york.ac.uk
